Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Jacobs

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Nature Biotechnology|May 1, 2002
Elan's attack of EnronitisTom Jacobs
Nature Biotechnology|September 3, 2002
Just mad about mAbsTom Jacobs
Nature Biotechnology|November 1, 2002
Is your biotech giving away the store?Tom Jacobs
Nature Biotechnology|June 29, 2002
A summer financial makeoverTom Jacobs
Nature Biotechnology|April 1, 2003
Fighting company spinTom Jacobs
Nature Biotechnology|October 13, 2006
Biotech buybacks--good or bad?Tom Jacobs
Nature Biotechnology|September 2, 2004
Does biotech M&A benefit investors?Tom Jacobs
Nature Biotechnology|November 10, 2006
Robbing Peter to pay PaulTom Jacobs
Nature Biotechnology|July 9, 2005
When a long shot is worth a shotTom Jacobs, Jeff Fischer
Statistics in Medicine|August 9, 2017
Comparing sampling methods for pharmacokinetic studies using model averaged derived parametersHelen Yvette Barnett, Helena Geys, Tom Jacobs, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Nature Biotechnology|May 1, 2002
Elan's attack of EnronitisTom Jacobs
Nature Biotechnology|September 3, 2002
Just mad about mAbsTom Jacobs
Nature Biotechnology|November 1, 2002
Is your biotech giving away the store?Tom Jacobs
Nature Biotechnology|June 29, 2002
A summer financial makeoverTom Jacobs
Nature Biotechnology|April 1, 2003
Fighting company spinTom Jacobs
Nature Biotechnology|October 13, 2006
Biotech buybacks--good or bad?Tom Jacobs
Nature Biotechnology|September 2, 2004
Does biotech M&A benefit investors?Tom Jacobs
Nature Biotechnology|November 10, 2006
Robbing Peter to pay PaulTom Jacobs
Nature Biotechnology|July 9, 2005
When a long shot is worth a shotTom Jacobs, Jeff Fischer
Statistics in Medicine|August 9, 2017
Comparing sampling methods for pharmacokinetic studies using model averaged derived parametersHelen Yvette Barnett, Helena Geys, Tom Jacobs, et al.
Pageof 9